Publicaciones en las que colabora con Bruno Carlos Sangro Gómez-Acebo (21)

2023

  1. Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience

    Cancers, Vol. 15, Núm. 3

2018

  1. Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience

    Clinical and Translational Oncology, Vol. 20, Núm. 5, pp. 658-665

  2. Selective internal radiation therapy: an effective treatment for hormonal syndromes in pancreatic neuroendocrine tumors

    HEPATIC ONCOLOGY, Vol. 5, Núm. 2

2017

  1. Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases

    Future Oncology, Vol. 13, Núm. 23, pp. 2065-2082

2013

  1. Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors

    World Journal of Gastroenterology, Vol. 19, Núm. 19, pp. 2935-2940

  2. Prognostic factors and prevention of radioembolization-induced liver disease

    Hepatology, Vol. 57, Núm. 3, pp. 1078-1087

2011

  1. Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients

    Journal of Immunology, Vol. 187, Núm. 11, pp. 6130-6142

2010

  1. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors

    CardioVascular and Interventional Radiology, Vol. 33, Núm. 3, pp. 523-531

2008

  1. Liver disease induced by radioembolization of liver tumors: Description and possible risk factors

    Cancer, Vol. 112, Núm. 7, pp. 1538-1546

2006

  1. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma

    International Journal of Radiation Oncology Biology Physics, Vol. 66, Núm. 3, pp. 792-800

2005

  1. Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas

    Journal of Clinical Oncology, Vol. 23, Núm. 5, pp. 999-1010

2004

  1. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors

    Journal of Clinical Oncology, Vol. 22, Núm. 8, pp. 1389-1397

2003

  1. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis

    Gastroenterology, Vol. 124, Núm. 4, pp. 1037-1042

  2. Gene therapy of neoplastic liver diseases

    International Journal of Biochemistry and Cell Biology, Vol. 35, Núm. 2, pp. 135-148

  3. Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion

    Human Gene Therapy, Vol. 14, Núm. 5, pp. 463-472

  4. The promise of gene therapy in gastrointestinal and liver diseases

    Gut

2002

  1. Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen

    Clinical Cancer Research, Vol. 8, Núm. 10, pp. 3219-3225

2001

  1. Idiopathic adulthood ductopenia. Long-term follow-up after liver transplantation

    Digestive Diseases and Sciences, Vol. 46, Núm. 7, pp. 1420-1423

  2. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma

    Liver Transplantation, Vol. 7, Núm. 7, pp. 631-636

1998

  1. Erratum: Prognosis of hepatocellular carcinoma in relation to treatment: A multivariate analysis of 178 patients from a single European institution (Surgery (1998) 124 (575-583))

    Surgery